Company Overview
Snapshot
Founded in October 2020 by Shlomi Uziel and Prof. Chen Shapira, Quai MD operates with 11–50 employees. The company has secured funding across 3 rounds from 7 investors, including Labs/02. In July 2024, Quai MD received a grant from the BIRD Foundation.
Business overview
Quai MD develops an AI-based clinical pathways platform designed to enhance patient care and boost revenue for healthcare systems. Its core technology provides a "clinical GPS" that guides physicians through the care process, standardizing decision-making with personalized, AI-driven clinical pathways. The company primarily serves healthcare providers and hospitals within the Digital Healthcare sector, focusing on medical decision support.
Strategic signal
In July 2024, Quai MD received a grant from the BIRD Foundation for a new project, signaling continued external validation and support for its AI-driven healthcare solutions. This grant, alongside private-sector funding for six new projects between Israeli and American companies, indicates a strong growth trajectory and potential for expanded partnerships and market penetration in the healthcare IT sector.
Log in to access full profile ›Company Intelligence Q&A
- What significant grant did Quai MD receive recently?
- In July 2024, Quai MD received a grant from the BIRD Foundation as part of $6.55 million in funding approved for six new projects between Israeli and American companies.
- What was the focus of Quai MD's platform development in August 2023?
- In August 2023, Quai MD was focused on developing an AI-based platform to help doctors diagnose patients with chest issues in real time, with an expected operational launch in the emergency room at the Medical University of South Carolina in early 2024.
- What strategic agreement did Quai MD enter into in November 2022?
- In November 2022, Quai MD and the Medical University of South Carolina health system (MUSC Health) entered into a strategic licensing agreement to advance their AI-based clinical pathways platform, with implementation set to begin in 2023.
- Which investor led Quai MD's funding round in August 2022?
- In August 2022, Labs/02 led a funding round for Quai MD, which also saw participation from.